<DOC>
	<DOCNO>NCT01764230</DOCNO>
	<brief_summary>Chemotherapy one basic modality oncology treatment often leave permanent implication among common infertility result irreversible gonadal damage . This project set primary target verify protective effect GnRH analogues administration protect ovarian tissue three different regimen chemotherapy patient Hodgkin disease ( HD ) reproductive age .</brief_summary>
	<brief_title>Prevention Ovarian Function Damage GnRH Analogue During Chemotherapy Hodgkin Lymphoma Patients</brief_title>
	<detailed_description>During first two year project duration curative anti-tumorous combine treatment fertile patient Hodgkin disease diagnosis carry . Patients divide three group accord clinical stage disease treat three type chemotherapeutic regimen comparable toxicity . Patients receive GnRH analogue chemotherapy gonadal protection mechanism foliculogenesis inhibition pre-pubertal stage . At end successful treatment accord state criterion ovarian function every patient repeatedly evaluate relation toxicity chemotherapy use . These ovarian function result compare control group patient without gonadal protection , reproductive function evaluate accord method .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>diagnosis Hodgkin lymphoma FSH LH level peripheral blood 15 IU/l fertile age 18 35 year female presence ovary ovarian tumour cysts 40 mm diameter</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Hodgkin lymphoma</keyword>
	<keyword>Hodgkin disease</keyword>
</DOC>